Kelso Pharma’s European growth story continues with appointment of new General Manager in Italy
Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, Giovanni Mauri, as General Manager at Velit Biopharma, the Italian-based pharma business that was acquired by Kelso Pharma in November 2023. With a wealth of experience across a variety of key markets in the life sciences sector, Giovanni Mauri specialises in […]
Kelso Pharma acquires UK pharma business, ALTURiX
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Holdings Limited (ALTURiX). The transaction marks a significant step towards Kelso’s vision of building a specialty pharma business of scale in the UK and ultimately […]
Kelso Pharma appoints first Director of Corporate Development as international expansion continues
Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, John Rooper, as Director of Corporate Development as the company eyes further growth across international markets. With a wealth of experience in the life sciences sector after working at Ernst and Young (EY) in a senior Mergers and Acquisitions (M&A) role […]
Stirling Anglian Pharmaceuticals launches new website with focus on providing patients with value-based solutions to healthcare
Stirling Anglian Pharmaceuticals (SAP), part of the Kelso Pharma Group, has launched its brand-new website, focusing on their products, corporate responsibility and plans for sustainability moving forward. SAP is a UK based pharmaceutical company, part of the Kelso Pharma Group, with a purpose of bringing innovative, value added, specialty branded medicines to patients across the […]
Kelso Pharma closes acquisition of Italian specialty pharma company, Velit Biopharma
The acquisition of Italian specialty pharma company, Velit Biopharma (Velit), by UK-based specialty pharma business, Kelso Pharma (Kelso), announced on 13th November 2023, has now closed. This is the first step for Kelso in its European expansion strategy and Velit is now part of the Kelso group of companies, which also includes Glasgow-based Stirling Anglian […]
Kelso Pharma announces strategic partnerships with PharmaPath and Valpharma
Kelso Pharma, the growing UK-based specialty pharma business, has concluded two new collaboration agreements with pharmaceuticals companies, PharmaPath and Valpharma. The specific products are not being disclosed at this time but the partnerships will add a new therapeutic area to the product portfolio of Kelso Pharma and its UK subsidiary, Stirling Anglian Pharmaceuticals (SAP). PharmaPath, […]
Kelso Pharma initiates European expansion with acquisition of Italian specialty pharma company, Velit Biopharma
Kelso Pharma (Kelso), the growing UK-based specialty pharma business, has taken its first step in its European expansion strategy by agreeing to acquire Italian specialty pharma company, Velit Biopharma (Velit). With more than 100 partnership agreements in place with pharma companies in Europe, Asia and the Middle East, Velit has a portfolio of more than […]
Kelso Pharma announces two UK product acquisitions as growth continues
Kelso Pharma, the growing UK-based specialty pharma business, has concluded a deal to acquire two UK approved products, representing an exciting launch into the specialty of Dermatology with prescription medicines for the treatment of actinic keratoses and plaque psoriasis. The two dermatology products, purchased from an organisation within the Dermapharm Group, represent another exciting move […]
Kelso Pharma announces first product launch
Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro® (Acetylcysteine) 600mg effervescent tablets. Acepiro (Acetylcysteine) is indicated in adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity […]
Kelso Pharma appoints Life Sciences leader as Chairman
Kelso Pharma, the growing specialty pharma business, has appointed senior Life Sciences executive, Gordon Cameron OBE, as its Non-Executive Chairman.
